Prevention and treatment of chemotherapy related fatty liver disease and hepatitis B virus reactivation in breast cancer patients during chemotherapy
10.3760/cma.j.issn.1674-6090.2017.05.020
- VernacularTitle:乳腺癌患者化疗性脂肪肝和乙肝病毒再激活的防治
- Author:
Yutuan WU
1
;
Lingquan KONG
;
Hongyuan LI
;
Guosheng REN
;
Kainan WU
Author Information
1. 400016,重庆医科大学附属第一医院内分泌乳腺外科
- Keywords:
Breast cancer;
Chemotherapy related fatty liver disease;
Hepatitis B virus reactivation
- From:
Chinese Journal of Endocrine Surgery
2017;11(5):426-429
- CountryChina
- Language:Chinese
-
Abstract:
Chemotherapy plays an important role in the comprehensive treatment of breast cancer,and chemotherapy related fatty liver disease (CRFLD) and hepatitis B virus (HBV) reactivation were still ignored at present.It would cause great influence on the patient's outcome.Preventive measures on them will be discussed in this paper.
